Patient-reported impact of symptoms in schizophrenia scale (PRISS): Development and validation

被引:2
|
作者
Moreno-Kustner, Berta [1 ,2 ,3 ,4 ]
Fabrega-Ruz, Julia [5 ]
Luis Gonzalez-Caballero, Juan [4 ,6 ]
Reyes-Martin, Sara [3 ]
Ochoa, Susana [4 ,7 ,8 ]
Romero-Lopez-Alberca, Cristina [4 ,8 ,9 ]
Cid, Jordi [4 ,10 ,11 ]
Vila-Badia, Regina [7 ,8 ]
Frigola-Capell, Eva [10 ,11 ]
Salvador-Carulla, Luis [4 ,12 ,13 ]
机构
[1] Univ Malaga, Dept Personal Assessment & Psychol Treatment, Malaga, Spain
[2] Andalusian Grp Psychosocial Res GAP, Andalucia, Spain
[3] Biomed Res Inst Malaga IBIMA, Malaga, Spain
[4] Assoc Cient Psicost, Cadiz, Spain
[5] Univ Malaga, Reg Univ Hosp Malaga, Mental Hlth Dept, Malaga, Spain
[6] Univ Cadiz, Fac Med, Dept Stat & Operat Res, Cadiz, Spain
[7] Parc Sanitari St Joan de Deu, Inst Recerca St Joan de Deu, Etiopathogenesis & Treatment Severe Mental Disord, Barcelona, Spain
[8] Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain
[9] Univ Cadiz, Dept Psychol, Cadiz, Spain
[10] Inst Assistencia Sanitaria Girona, Girona, Spain
[11] Inst Invest Biomed Girona IDIBGI, Mental Hlth & Addict Res Grp, Girona, Spain
[12] Univ Canberra, Fac Hlth, Hlth Res Inst, Canberra, ACT, Australia
[13] Univ Sydney, Menzies Ctr Mental Hlth Policy, Sydney Sch Publ Hlth, Sydney, NSW, Australia
关键词
patient-reported outcome; patient-reported outcome measure; schizophrenia; subjective experiences; NEGATIVE SYNDROME SCALE; PSYCHOMETRIC PROPERTIES; PANSS; COEFFICIENT; AGREEMENT; RELIABILITY; DEFINITION; VALIDITY; SAMPLE; HEALTH;
D O I
10.1111/acps.13417
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background We report the psychometric properties of the Patient-Reported Impact of Symptoms in Schizophrenia Scale (PRISS), which assesses the impact of subjective experiences or qualia in outpatients with this condition. Methods A cross-sectional study was carried out in 162 patients diagnosed with schizophrenia in Spain. The PRISS measures the presence, frequency, concern and interference with daily life of self-reported experiences related to the main symptoms observed in these patients. The psychometric analysis included test-retest reliability, internal consistency and structural and convergent validity. Results The 28-item PRISS showed good test-retest reliability as 64.3% of the intraclass correlation coefficient values were between 0.40 and 0.79, which were statistically significant (p < 0.01). Analysis of the structural validity revealed a three-factor structure, (1) productive subjective experiences, (2) affective-negative subjective experiences and (3) excitation, which accounted for 56.11% of the variance. Of the Pearson's correlation coefficients analysed between the PRISS and the Positive and Negative Syndrome Scale (PANSS), Scale for Assessment of Negative Symptoms (SANS) and World Health Organization Disability Assessment Schedule (WHO-DAS), 72.2% were statistically significant (p < 0.05) and ranged from 0.38-0.42, 0.32-0.42 and 0.40-0.42, respectively. Conclusion Our results indicate that the PRISS appears to be a brief, reliable and valid scale to measure subjective experiences in schizophrenia and provides valuable information complementary to clinical evaluation.
引用
下载
收藏
页码:640 / 655
页数:16
相关论文
共 50 条
  • [21] PATIENT-CENTRED DEVELOPMENT AND VALIDATION OF THE PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD) MEASURE
    Pattinson, Rachael
    Trialonis-Suthakharan, Nirohshah
    Austin, Jennifer
    FitzGerald, Allison
    Augustin, Matthias
    Bundy, Chris
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 10 - 10
  • [22] PATIENT-CENTRED DEVELOPMENT AND VALIDATION OF THE PATIENT-REPORTED IMPACT OF DERMATOLOGICAL DISEASES (PRIDD) MEASURE
    Pattinson, Rachael
    Trialonis-Suthakharan, Nirohshah
    Austin, Jennifer
    FitzGerald, Allison
    Augustin, Matthias
    Bundy, Chris
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 10 - 10
  • [23] Patient-reported outcomes in schizophrenia
    McCabe, Rosemarie
    Saidi, Marya
    Priebe, Stefan
    BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 : S21 - S28
  • [24] Development and evaluation of a measure of patient-reported symptoms of Blepharitis
    Hosseini, Kamran
    Bourque, Linda B.
    Hays, Ron D.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2018, 16
  • [25] Development and validation of a patient-reported scale for tolerability of endoscopic procedures using conscious sedation
    Forbes, Nauzer
    Chau, Millie
    Koury, Hannah F.
    Lethebe, B. Cord
    Smith, Zachary L.
    Wani, Sachin
    Keswani, Rajesh N.
    Elmunzer, B. Joseph
    Anderson, John T.
    Heitman, Steven J.
    Hilsden, Robert J.
    GASTROINTESTINAL ENDOSCOPY, 2021, 94 (01) : 103 - +
  • [26] Development and evaluation of a measure of patient-reported symptoms of Blepharitis
    Kamran Hosseini
    Linda B. Bourque
    Ron D. Hays
    Health and Quality of Life Outcomes, 16
  • [27] Development and validation of a patient-reported usefulness scale to evaluate antiepileptic pharmacotherapy in patients with epilepsy
    Brown, LM
    Mulani, P
    Cifaldi, M
    Ashraf, T
    VALUE IN HEALTH, 2004, 7 (03) : 234 - 234
  • [28] Development and Validation of a Patient-Reported Outcome Measure of Ataxia
    Schmahmann, Jeremy D.
    Pierce, Samantha
    MacMore, Jason
    L'Italien, Gilbert J.
    MOVEMENT DISORDERS, 2021, 36 (10) : 2367 - 2377
  • [29] Patient-reported and clinician-rated depressive symptoms in the treatment of schizophrenia
    Conley, R
    Ascher-Svanum, H
    Zhu, BJ
    Faries, D
    Kinon, B
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S121 - S122
  • [30] Sex differences in patient-reported outcome measure of psychotic symptoms in schizophrenia
    Vila-Badia, Regina
    Ochoa, Susana
    Fabrega-Ruz, Julia
    Gonzalez-Caballero, Juan Luis
    Romero, Cristina
    Cid, Jordi
    Frigola-Capell, Eva
    Salvador-Carulla, Luis
    Moreno-Kuestner, Berta
    ARCHIVES OF WOMENS MENTAL HEALTH, 2024, 27 (05) : 721 - 729